GetTopicDetailResponse(id=8c6d99069da, topicName=青黛, introduction=青黛, content=null, image=null, comments=1, allHits=1728, url=https://h5.medsci.cn/topic?id=99069, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57123, tagList=[TagDto(tagId=57123, tagName=青黛)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2245332, encodeId=1d782245332c0, content=<a href='/topic/show?id=e2a54816ecc' target=_blank style='color:#2F92EE;'>#巨噬細胞#</a> <a href='/topic/show?id=98c0553894c' target=_blank style='color:#2F92EE;'>#抗炎#</a> <a href='/topic/show?id=d051523897d' target=_blank style='color:#2F92EE;'>#急性肺損傷#</a> <a href='/topic/show?id=8c6d99069da' target=_blank style='color:#2F92EE;'>#青黛#</a> <a href='/topic/show?id=5e04120949a7' target=_blank style='color:#2F92EE;'>#JAK2/STAT3#</a>, objectTitle=J Inflamm Res：中藥青黛通過抑制JAK2/STAT3信號通路減輕急性肺損傷的機制, objectType=article, longId=857212, objectId=c1e985e21256, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241227/1735315021399_5610093.jpg, objectUrl=/article/show_article.do?id=c1e985e21256, replyNumber=0, likeNumber=53, createdTime=2024-12-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c1e985e21256, moduleTitle=J Inflamm Res：中藥青黛通過抑制JAK2/STAT3信號通路減輕急性肺損傷的機制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1e985e21256)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2131303, encodeId=a31a2131303ba, content=<a href='/topic/show?id=e56c10538865' target=_blank style='color:#2F92EE;'>#靛玉紅#</a>是從中藥<a href='/topic/show?id=8c6d99069da' target=_blank style='color:#2F92EE;'>#青黛#</a>（Indigofera tinctoria L）中分離出來的抗<a href='/topic/show?id=1991e1775c9' target=_blank style='color:#2F92EE;'>#白血病#</a>的有效成分，為一雙吲哚類抗腫瘤藥物。有抗癌作用，臨床用于治療<a href='/topic/show?id=69da53614b0' target=_blank style='color:#2F92EE;'>#慢性粒細胞白血病#</a>。
中藥<a href='/topic/show?id=6daf1062011c' target=_blank style='color:#2F92EE;'>#靛玉紅衍生物#</a>BiA制成的合成<a href='/topic/show?id=d8d5e7476de' target=_blank style='color:#2F92EE;'>#納米顆粒#</a>配方—PPRX-1701，可通過抑制<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#腫瘤微環(huán)境#</a>的關鍵酶<a href='/topic/show?id=2853942e78' target=_blank style='color:#2F92EE;'>#IDO1#</a>的表達，從而阻斷<a href='/topic/show?id=01858406438' target=_blank style='color:#2F92EE;'>#膠質(zhì)母細胞瘤#</a>的生長，提高生存率。
不過，IDO1抑制劑/抗體用于<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#腫瘤#</a>的治療是失敗的，至少表明IDO1不是最核心的免疫因子。, objectTitle=哈佛大學新研究：中藥靛玉紅衍生物，或可治療致命膠質(zhì)母細胞瘤, objectType=article, longId=770935, objectId=aaa6e7093547, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019371411_4754896.png, objectUrl=/article/show_article.do?id=aaa6e7093547, replyNumber=0, likeNumber=185, createdTime=2023-05-10, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=aaa6e7093547, moduleTitle=哈佛大學新研究：中藥靛玉紅衍生物，或可治療致命膠質(zhì)母細胞瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aaa6e7093547)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
2020-05-29
